Systems pharmacology approaches for optimization of antiangiogenic therapies: challenges and opportunities

Por Sharan, Satish, Woo, Sukyung
Publicado no Front Pharmacol (2015)

CXCR2 Inhibition Combined with Sorafenib Improved Antitumor and Antiangiogenic Response in Preclinical Models of Ovarian Cancer

Por Devapatla, Bharat, Sharma, Ankur, Woo, Sukyung
Publicado no PLoS One (2015)

Pharmacodynamic model for chemotherapy-induced anemia in rats

Por Woo, Sukyung, Krzyzanski, Wojciech, Jusko, William J.
Publicado em 2007

Methods of utilizing baseline values for indirect response models

Por Woo, Sukyung, Pawaskar, Dipti, Jusko, William J.
Publicado em 2009

Scaling Pharmacodynamics from In Vitro and Preclinical Animal Studies to Humans

Por Mager, Donald E., Woo, Sukyung, Jusko, William J.
Publicado em 2009

Anticancer Drug Released from Near IR-activated Prodrug Overcomes Spatiotemporal Limits of Singlet Oxygen

Por Rajaputra, Pallavi, Bio, Moses, Nkepang, Gregory, Thapa, Pritam, Woo, Sukyung, You, Youngjae
Publicado no Bioorg Med Chem (2016)

Far-red Light-activatable Prodrug of Paclitaxel for the Combined Effects of Photodynamic Therapy and Site-specific Paclitaxel Chemotherapy

Por Thapa, Pritam, Li, Mengjie, Bio, Moses, Rajaputra, Pallavi, Nkepang, Gregory, Sun, Yajing, Woo, Sukyung, You, Youngjae
Publicado no J Med Chem (2016)

Folate-PEG Conjugates of a Far-Red Light-Activatable Paclitaxel Prodrug to Improve Selectivity toward Folate Receptor-Positive Cancer Cells

Por Thapa, Pritam, Li, Mengjie, Karki, Radha, Bio, Moses, Rajaputra, Pallavi, Nkepang, Gregory, Woo, Sukyung, You, Youngjae
Publicado no ACS Omega (2017)

A Phase I Study of Oral Lenalidomide in Patients with Refractory Metastatic Cancer

Por Dahut, William L., Aragon-Ching, Jeanny B., Woo, Sukyung, Tohnya, Tanyifor M., Gulley, James L., Arlen, Philip M., Wright, John J., Figg, William D.
Publicado em 2009

Population pharmacokinetic analysis of sorafenib in patients with solid tumours

Por Jain, Lokesh, Woo, Sukyung, Gardner, Erin R, Dahut, William L, Kohn, Elise C, Kummar, Shivaani, Mould, Diane R, Giaccone, Giuseppe, Yarchoan, Robert, Venitz, Jürgen, Figg, William D
Publicado em 2011

Safety and Feasibility of Long-term Intravenous Sodium Nitrite Infusion in Healthy Volunteers

Por Pluta, Ryszard M., Oldfield, Edward H., Bakhtian, Kamran D., Fathi, Ali Reza, Smith, René K., DeVroom, Hetty L., Nahavandi, Masoud, Woo, Sukyung, Figg, William D., Lonser, Russell R.
Publicado em 2011

Population pharmacokinetics of romidepsin in patients with cutaneous T-cell lymphoma and relapsed peripheral T-cell lymphoma

Por Woo, Sukyung, Gardner, Erin R., Chen, Xiaohong, Ockers, Sandra B., Baum, Caitlin E., Sissung, Tristan M., Price, Douglas K., Frye, Robin, Piekarz, Richard L., Bates, Susan E., Figg, William D.
Publicado em 2009

A Phase I Clinical Study of High-Dose Ketoconazole Plus Weekly Docetaxel in Metastatic Castration-Resistant Prostate Cancer

Por Figg, William D., Woo, Sukyung, Zhu, Wenhui, Chen, Xiaohong, Ajiboye, Atinuke, Steinberg, Seth M., Price, Douglas K., Wright, John J., Parnes, Howard L., Arlen, Philip M., Gulley, James L., Dahut, William L.
Publicado em 2010

Phase II Trial of Bevacizumab, Thalidomide, Docetaxel, and Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer

Por Ning, Yang-Min, Gulley, James L., Arlen, Philip M., Woo, Sukyung, Steinberg, Seth M., Wright, John J., Parnes, Howard L., Trepel, Jane B., Lee, Min-Jung, Kim, Yeong Sang, Sun, Haihao, Madan, Ravi A., Latham, Lea, Jones, Elizabeth, Chen, Clara C., Figg, William D., Dahut, William L.
Publicado em 2010

Impact of ABCB1 allelic variants on QTc interval prolongation

Por Sissung, Tristan M., Gardner, Erin R., Piekarz, Richard L., Howden, Reuben, Chen, Xaiohong, Woo, Sukyung, Franke, Ryan, Clark, James A., Miller-DeGraff, Laura, Steinberg, Seth M., Venzon, David, Liewehr, David, Kleeberger, Steven R., Bates, Susan E., Price, Douglas K., Rosing, Douglas R., Cabell, Christopher, Sparreboom, Alex, Figg, William D.
Publicado em 2010